Attributable mortality of candidemia after introduction of echinocandins,Mycoses

当前位置： X-MOL 学术 › Mycoses › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Attributable mortality of candidemia after introduction of echinocandins
Mycoses ( IF 4.1 ) Pub Date : 2020-09-27 , DOI: 10.1111/myc.13177
Florian B Cornely _{1,

2} , Oliver A Cornely _{1,

3,

4,

5} , Jon Salmanton-García _{1,

3} , Felix C Koehler _{3,

6} , Philipp Koehler _{1,

3} , Harald Seifert _{5,

7} , Sebastian Wingen-Heimann _{3,

8} , Sibylle C Mellinghoff _{1,

3}

Affiliation

Candidemia is among the most frequent nosocomial bloodstream infections. Landmark case‐control studies on amphotericin B and fluconazole estimated attributable mortality rates of 38% and 49%, respectively. After introduction of echinocandins, these may have decreased.

中文翻译：